Switching From Pregabalin to Mirogabalin in Patients with Peripheral Neuropathic Pain: A Multi-Center, Prospective, Single-Arm, Open-Label Study (MIROP Study)

INTRODUCTION: Mirogabalin, which is a selective ligand of the α(2)δ subunit of voltage-gated Ca(2+) channels, was recently approved in Japan for peripheral neuropathic pain. The α(2)δ ligands, including mirogabalin and pregabalin, are associated with significant risk of adverse events (AEs) such as...

Descripción completa

Detalles Bibliográficos
Autores principales: Kimura, Yoshiyuki, Yamaguchi, Shigeki, Suzuki, Takahiro, Kato, Jitsu, Chiba, Satoko, Hirakawa, Naomi, Yamaguchi, Keisuke, Tanabe, Yutaka, Takatsuna, Hiroshi, Kenyoshi, Yusuke, Shiosakai, Kazuhito, Sakai, Miyoshi, Iseki, Masako
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119591/
https://www.ncbi.nlm.nih.gov/pubmed/33856660
http://dx.doi.org/10.1007/s40122-021-00255-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119591/
https://www.ncbi.nlm.nih.gov/pubmed/33856660
http://dx.doi.org/10.1007/s40122-021-00255-y

Ejemplares similares